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Heat-shock protein 104 (Hsp104p) is a protein-remodeling factor that promotes survival after extreme stress by disassem-
bling aggregated proteins and can either promote or prevent the propagation of prions (protein-based genetic elements).
Hsp104p can be greatly overexpressed without slowing growth, suggesting tight control of its powerful protein-remod-
eling activities. We isolated point mutations in Hsp104p that interfere with this control and block cell growth. Each
mutant contained alterations in the middle region (MR). Each of the three MR point mutations analyzed in detail had
distinct phenotypes. In combination with nucleotide binding site mutations, Hsp104pT499I altered bud morphology and
caused septin mislocalization, colocalizing with the misplaced septins. Point mutations in the septin Cdc12p suppressed
this phenotype, suggesting that it is due to direct Hsp104p–septin interactions. Hsp104pA503V did not perturb morphology
but stopped cell growth. Remarkably, when expressed transiently, the mutant protein promoted survival after extreme
stress as effectively as did wild-type Hsp104p. Hsp104pA509D had no deleterious effects on growth or morphology but had
a greatly reduced ability to promote thermotolerance. That mutations in an 11-amino acid stretch of the MR have such
profound and diverse effects suggests the MR plays a central role in regulating Hsp104p function.
INTRODUCTION
The AAA proteins are ATPases associated with various
cellular activities. They are important proteins with a great
diversity of functions, including protein folding, membrane
trafficking, organelle biogenesis, proteolysis, intracellular
motility, and DNA replication (Neuwald et al., 1999; Vale,
2000; Ogura and Wilkinson, 2001). Little is known about
how most AAA proteins recognize substrates and use ATP
binding and hydrolysis to remodel them. The intrinsic com-
plexity and multiplicity of conformational states of the
AAA proteins make them difficult to study. The Clp/
HSP100 proteins are members of the AAA superfamily and
have been the subject of intense biochemical analysis in vitro
and genetic analysis in vivo (Wickner et al., 1999; Glover and
Tkach, 2001). The functional unit of the yeast HSP100 heat-
shock protein 104 (Hsp104p) is composed of six monomers,
each with two ATP binding sites (nucleotide binding do-
mains one and two; NBD1 and NBD2) flanked by amino-
terminal, middle, and carboxy-terminal regions (Figure 1).
Hsp104p has remarkable functions, one of which is to
allow survival after extreme stress. For example, yeast cells
expressing Hsp104p are 1000 times more viable after expo-
sure to temperatures 50°C or to an ethanol concentration
of 20% than cells carrying deletions of HSP104 (Sanchez and
Lindquist, 1990; Sanchez et al., 1992). This survival capacity
is directly attributable to Hsp104p’s ability to resolubilize
protein aggregates and, together with Hsp70p and Hsp40p,
return them to their folded and active states (Parsell et al.,
1994; Glover and Lindquist, 1998; Goloubinoff et al., 1999).
This is in contrast to other heat shock proteins, which gen-
erally act by preventing aggregate accumulation or by pro-
moting the degradation of misfolded proteins (Schirmer et
al., 1996; Zolkiewski, 1999). During times of severe stress, the
rate of protein aggregation exceeds the capacity of other heat
shock proteins to prevent aggregate accumulation, and
Hsp104p becomes critical to survival. This explains the ob-
servation that Hsp104p is not required for normal growth, or
even growth at high temperatures, but is vital for surviving
extreme conditions. The relationship between Hsp104p and
thermotolerance is simple and direct: the more Hsp104p
present, the higher the level of thermotolerance.
Another remarkable activity of Hsp104p is prion mainte-
nance (Chernoff et al., 1995; Patino et al., 1996; Paushkin et al.,
1996; DebBurman et al., 1997; Moriyama et al., 2000). Prions
are proteinaceous genetic elements that have the ability to
undergo heritable, self-perpetuating changes in conforma-
tion. As with stress survival, prion maintenance is depen-
dent on Hsp104p’s control of protein aggregation, but in this
case the relationship is more complex. For maintenance of
the [PSI] prion, intermediate levels of Hsp104p are neces-
sary: either deletion or overexpression of HSP104 eliminates
[PSI].
The importance of the ATP hydrolysis sites in the
Hsp104p NBD regions is apparent from the debilitating
effects of mutations in either NBD1 or NBD2 on thermotol-
erance and prion maintenance (Parsell et al., 1991; Chernoff
et al., 1995; Patino et al., 1996; Schirmer et al., 2001) and from
the well documented importance of these domains in other
AAA proteins (Ogura and Wilkinson, 2001; Lupas and
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Martin, 2002). The function of Hsp104p’s other domains,
which are much more variable between different members
of the AAA superfamily, and how they cooperate with the
NBDs to accomplish varied protein-remodeling actions, re-
main mysterious.
As an alternative to using site-directed mutagenesis to
investigate the functions of domains of predefined impor-
tance, here we undertook the first genetic screen to identify
other critical residues. The mutations recovered, and their
analysis, establish that the middle region (MR) has crucial
roles in Hsp104p function.
MATERIALS AND METHODS
Yeast Strains and Media
Plasmids (see below) were introduced into Saccharomyces cerevisiae strain
LP112, W303a (an isogenic haploid), or SL304A (a W303a derivative with
HSP104 codons 1–321 replaced by LEU2) (Table 1). To allow use of LEU2 as
an auxotrophic marker in suppressor screens, a new hsp104 strain, A3224,
was created in which HSP104 codons 18–892 in W303a were replaced by kanr
by using pFA6a-kanMX4 (Wach et al., 1994) as template to generate the
desired polymerase chain reaction (PCR) product; the screen itself was con-
ducted in a modified variant, A3330, with a galactose-inducible LacZ reporter
integrated at the HIS3 locus. The pRS303-LacZ reporter was created for this
study by transferring LacZ (BamHI/XbaI) from pCM171 (Gari et al., 1997) to
pRS303:GAL1–10. Strains A3685 and A3686 were derived from the originally
isolated suppressor strains by mating each to W303, sporulating, and select-
ing strains that maintained the suppressor phenotype but had lost the trans-
poson insertion and LacZ reporter.
Transformants were maintained on synthetic dextrose medium (SD)
(Schirmer et al., 1994). Raffinose (SR) or galactose (SG) replaced dextrose in
this medium to preadapt and induce GAL1-regulated plasmids, respectively.
(Raffinose relieves glucose repression, allowing more rapid induction by
galactose.) In strains that also carried plasmid GAL4.ER.VP16 (encoding a
chimeric transcriptional activator), galactose-regulated 104b-U1 plasmids
were induced in SD by 10 nM -estradiol. MET14-regulated genes were
induced by washing and incubation in SD lacking methionine.
Plasmids
A URA3-selected plasmid carrying GAL1-regulated HSP104 was used for the
mutagenesis screen (Table 2, pYS-GAL104). Subsequent experiments used a
Figure 1. Mutations recovered in the screen for dominant lethal HSP104 mutants. Hsp104p (908 amino acids) has two highly conserved but
distinct NBDs (NBD1 and NBD2) flanked by less conserved N-terminal and C-terminal regions. The MR is an insertion within NBD1. The
boundaries of NBD1 (according to an alignment of AAA protein sequences; Neuwald et al., 1999) are from residue 180 to residue 400 and
again from residue 549 to residue 586 for the sensor 2 domain. The MR is the area bounded by these regions (residue 401 to residue 548).
Areas of greater conservation are denoted by a thicker line (Schirmer et al., 1996), and signature sequences of the NBDs are denoted: A and
B, the Walker-type P-loop motifs; S1 and S2, the two sensor regions. Asterisks indicate the positions of the mutations in sequenced mutants,
and the amino acid substitutions are specified on the left. Conserved sequence elements where mutations tended to cluster are further marked
by open boxes. The mutants are grouped by phenotype.
Table 1. Strains used in this study
Strain Genotype Source
E. coli
KC8 r-m leu B600 trpC9830 LacX74 strA galUK pyrFTn5 his B463 M. Casadaban
DH10B F-mcrA (mrr-hsdRMS-mcrBC) 80dlacZM15 lacX74 deoR recA1 endA1 ara139 Invitrogen
D(ara, leu)7697 galU galK -rpsL nupG
S. cerevisiae
LP112 MAT a/ leu2-3,112/leu2-3,112 trp1-1/trp1-1 ura3-1/ura3-1 ade2-1/ade2-1 his3-11,15/his3-11,15
lys2/lys2 can1-100/can1-100
R. Rothstein
W303a MAT a leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 lys2 can1-100 R. Rothstein
W303 MAT  leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 lys2 can1-100 R. Rothstein
SL304A MAT a leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 lys2 can1-100 hsp104LEU2 Sanchez and Lindquist, 1990
A3224 MAT a leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 lys2 can1-100 hsp104KanMX4 See text
A3330 MAT a leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15HIS3 (GAL1-LACZ) lys2 can1-100
hsp104KanMX4
See text
A3685 MAT a leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 lys2 can1-100 hsp104KanMX4 cdc12K351N See text
A3686 MAT a leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 lys2 can1-100 hsp104KanMX4 cdc12E368Q See text
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modified HSP104 plasmid that had three guanosine nucleotides inserted
before the ATG to lower basal expression in both yeast and Escherichia coli.
This plasmid also had additional unique restriction endonuclease sites every
500 base pairs that facilitated insertion of directed mutations but did not
change the protein sequence (HSP104R; Schirmer and Lindquist, 1998). The
GAL1:10 promoter was inserted between the BamHI and EcoRI sites of the
polylinker of the pRS300 series vectors (Sikorski and Hieter, 1989), converting
pRS303 into pRS303:GAL1–10, pRS313 into pLA1, pRS315 into pRS315:GAL1-
10, and pRS316 into pRS316:GAL1-10. HSP104R (BamHI to the SacI site after
the poly A) was then inserted behind the GAL1 promoter in the modified
vectors, converting pLA1 into pGALSc104, pRS315:GAL1-10 into HSP104-b/
Leu, and pRS316:GAL1-10 into 104b-U1.
Individual substitutions were introduced into each 500-base pair segment
from HSP104R in pBluescript KS by using the Muta-Gene M13 in vitro
mutagenesis kit (Bio-Rad, Hercules, CA). The segments were completely
sequenced and then replaced into the corresponding region of pGALSc104,
HSP104-b/Leu, or 104b-U1.
The wild-type CDC12 and suppressor cdc12K351N and cdc12E368Q genes were
amplified with and without 266 base pairs of upstream sequence (this 266
base pairs contains at least the partial endogenous promoter) from strains
A3330, A3685, and A3686, respectively (Table 1). Using primers that added
BamHI and XbaI sites, the amplified genes were cloned into pRS316 (266 base
pairs endogenous promoter; plasmid CDC12-WT) and pRS316:GAL1–10 (ex-
ogenous promoter; plasmid GAL-CDC12). GFP-CDC12 was constructed by
introducing a silent mutation into codon 2 of CDC12 (AGT 3 AGC) in
plasmid CDC12-WT to create an Eco47 III site into which green fluorescent
protein (GFP) (amplified from plasmid GFP-CDC3) was blunt-end cloned.
Mutagenesis Screen
pYS-GAL104 (10 g of DNA/500-l reaction) was mutagenized by incubation
with 1 M hydroxylamine (pH 5.5–6.5) at 75°C for 45–90 min (Busby et al.,
1982). After phenol-chloroform purification, 1/100 of each preparation was
transformed into KC8 bacteria (Table 1), and colonies were replica plated to
/ uracil plates to assess the mutagenesis frequency in the URA3 marker.
(URA3 rescues the bacterial pyrF mutation, similar to URA3 auxotrophic
selection in yeast.) The remainders of two preparations, with only small
(1–3%) losses of URA3 function, were transformed into yeast strain LP112,
and it was predicted from the URA3 mutation rate that only single substitu-
tions would be isolated in HSP104 (Sikorski and Boeke, 1991). Transformants
were selected on Ura glucose plates and replica plated onto two Ura
glucose (for HSP104 repression) and two Ura galactose (for HSP104 induc-
tion) plates. Cells were incubated at 25 or 37°C for 3–5 d, and strains exhib-
iting a significant reduction in growth on galactose compared with strains
containing unmutagenized plasmid were retested quantitatively by growing
in liquid SD to mid-log phase, equalizing cell densities, and spotting 5 l of
fivefold serial dilutions onto Ura glucose and Ura galactose plates.
To eliminate one class of false positives (growth inhibition on galactose due
to general respiratory deficiency), colonies on glucose plates were overlaid
with 20 ml of 0.75% Bacto agar in 0.067 M phosphate buffer, pH 7.0, contain-
ing 0.1% 2,3,5-triphenyltetrazolium chloride (Colson et al., 1974). After 3 h,
colonies were scored as respiration positive (red) or negative (white). A
second class of false positives (carrying extraneous growth-inhibiting
genomic mutations) was eliminated by testing to ensure that the growth-
inhibition phenotype depended upon maintenance of the HSP104 plasmid,
using 5-fluoro-orotic acid to select for plasmid loss (Boeke et al., 1984).
To determine the DNA sequences of the mutant plasmids, two overlapping
fragments were amplified from yeast by using HSP104 and vector primer
combinations. PCR products were completely sequenced on both strands, and
regions containing mutations were resequenced from independent amplifica-
tions.
Suppressor Screens
Two different suppressor screens were conducted in strain A3330 (Table 1)
carrying plasmid HSP104(G217S/T499I)-b/Leu. For the first screen, 4  109
cells were transformed with 200 g of a galactose-inducible genomic library
(ATCC 87311; Ramer et al., 1992), plated on Leu glucose and then replica-
plated to Leu galactose. Screening of 106 colonies yielded 534 suppressor
candidates. None passed a secondary screen for restoration of the
Hsp104pG217S/T499I phenotype upon loss of the library plasmid. For the
second screen, 108 cells were transformed with the mTN-3  HA/lacZ
library (provided by M. Snyder; Ross-Macdonald et al., 1997), plated on Ura
Leu glucose, and then replica plated to Ura Leu galactose. Screening
105 transformants yielded 90 strong candidate suppressors. Only nine of
these strains retained expression of the mutant Hsp104p, and seven could not
suppress a freshly introduced HSP104(G217S/T499I)-b/Leu plasmid.
The two remaining bona fide suppressors were due to random genomic
mutations and were not dependent on an integrated transposon. To isolate
these, a library was constructed from suppressor strain A3685 to identify the
dominant suppressor. Genomic DNA was partially digested with Sau 3AI,
and fragments of 4–10 kb were purified and ligated to BamHI-cut YCp50
(Rose et al., 1987). The resulting plasmids were amplified in Electromax
DH10B cells (Invitrogen, Carlsbad, CA) and transformed into A3224 cells
carrying HSP104(G217S/T499I)-b/Leu, and 105 colonies were screened for
suppression of the Hsp104pG217S/T499I growth phenotype.
Thermotolerance and ATPase Assays
Heat-stress treatments were conducted as described previously (Schirmer et
al., 1994). Briefly, mutant and wild-type proteins encoded in the pGALSc104
plasmid were induced in strain SL304A for 4 h in mid-log phase, and cells
were then heat shocked at 50°C with or without a preconditioning treatment
at 37°C, fivefold serially diluted, and spotted onto SD plates at 25°C to repress
further expression of the mutant Hsp104p. Induced cells that did not receive
a heat stress were plated onto SD and SG to confirm the growth-inhibition
phenotype of the plasmid they contained. Experiments were repeated at least
three times with strains isolated from independent transformations, yielding
similar results in all cases.
Proteins for ATPase assays were purified from E. coli as described by
Schirmer and Lindquist (1998) by using the pET28a expression vector (No-
vagen, Madison, WI), and the assays were performed as described by
Schirmer et al. (1998).
Table 2. Plasmids used
Name Genea Promoter Featuresb Use Source
pYS-GAL104 HSP104 GAL1 CEN, URA3 Original screen Sanchez and Lindquist 1990
pLA1 none GAL1 CEN, HIS3 Vector control for pGALSc104 L. Arwood and S. Lindquist
pGALSc104 HSP104/mutants GAL1 CEN, HIS3 Directed mutants See text
pRS316:GAL1-10 none GAL1 CEN, URA3 Vector control for 104b-U1 J. Taulien and S. Lindquist
I04b-U1 HSP104/mutants GAL1 CEN, URA3 Directed mutants See text
pRS315:GAL1-10 none GAL1 CEN, LEU2 Vector control for HSP104-b/Leu J. Taulien and S. Lindquist
HSP104-b/Leu HSP104/mutants GAL1 CEN, LEU2 Suppressor screen Ter-Avanesyan et al., 1993
TM104b HSP104/mutants MET14 CEN, TRP1 Alternative induction system E. Schirmer and S. Lindquist
GAL4.ER.VP16 GAL4/ER/VP16 ADH CEN, HIS3 Estradiol induction of GAL1 plasmids Louvion et al., 1993
pEMBL-3AUG SUP35 C-terminus SUP35 2m, URA3 Test suppression Ter-Avanesyan et al., 1993
pRS303-LacZ LacZ GAL1 none, HIS3 Integration into suppressor strain See text
CDC12-WT CDC12/mutants CDC12 CEN, URA3 Suppressor screen See text
GAL-CDC12 CDC12/mutants GAL1 CEN, URA3 Suppressor screen See text
GFP-CDC3 GFP-CDC3 CDC3 CEN, URA3 Septin visualization M. Longtine
GFP-CDC12 GFP-CDC12 CDC12 CEN, URA3 Septin visualization See text
a Plasmids containing directed mutants are indicated in the text by the plasmid name with the mutation in parentheses, e.g., pGALSc104
carrying a mutant G217S/T499I allele is designated pGALSc104(G217S/T449I).
b Features listed are yeast replication (CEN is low copy number and 2m is high copy number) and auxotrophic selection.
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Microscopy
SL304A cells carrying pGALSc104, its mutant variants, or the parent vector
were induced from mid-log phase for 7–13 h in SG. Cells were fixed for 1 h in
3.7% formaldehyde and permeabilized after cell wall removal with Triton
X-100, as described by Pringle et al. (1991). Next, the cells were incubated with
anti-Hsp104p antibody 8–1 (polyclonal to the C-terminal 15 residues; Parsell
and Lindquist, unpublished data), 4G-10 (monoclonal to the MR; Jison, Ra-
makrishnan, and Lindquist, unpublished data), or anti-septin antibodies (af-
finity purified, polyclonal) specific for Cdc11p (Ford and Pringle, 1991) or
Cdc3p (Kim et al., 1991). After incubation with the appropriate secondary
antibodies (Organon-Teknika, Durham, NC), images were obtained either on
an Olympus epifluorescence microscope and scanned from 35-mm slides, or
on an Axioplan 2 microscope interfaced with a LSM410 confocal module (Carl
Zeiss, Thornwood, NY) microscope with Openlab 2.25 software.
The same strain and plasmids used for the light/fluorescence microscopy
were similarly induced before fixation for electron microscopy. The electron
microscopy was carried out as described previously (Parsell et al., 1994).
Wild-type (A3224) and suppressor (A3685, A3686) strains carrying the
GFP-CDC3 and HSP104(G217S/T499I)-b/Leu plasmids were analyzed live
after a 12-h induction by using the Lab-Tek II chambered #1.5 German
coverglass system (Nalge Nunc International, Naperville, IL). Images were
obtained using an Axiovert S100TV microscope (Carl Zeiss) interfaced to a
Bio-Rad MRC1024 confocal system. All images were processed using Photo-
shop 6.
RESULTS
Screen for Mutations That Perturb the Regulated Function
of Hsp104p
Our approach was based on the observation that although
Hsp104p has powerful protein-remodeling functions, it can
be overexpressed at high levels without affecting growth
(Lindquist and Kim, 1996); thus, its broad capacity to inter-
act with varied substrates and remodel them must normally
be tightly controlled. Plasmids carrying HSP104 were ran-
domly mutagenized to determine whether Hsp104p is under
tight regulation, and if so, to identify critical regulatory
regions and residues. The mutants were screened for the
capacity to inhibit growth at normal temperatures. Such a
phenotype would reflect disruption of the normally tight
controls on Hsp104p activities.
Pools of plasmid carrying HSP104 under the control of a
galactose-inducible promoter (GAL1) were chemically mu-
tagenized to various extents (see MATERIALS AND METH-
ODS). To favor the recovery of single point mutations, the
frequency of mutations in a marker on the same plasmid
was used to select a pool with a relatively low mutation rate.
Wild-type cells transformed with these plasmids were
screened for the ability to grow on glucose (which represses
GAL1 expression) but not on galactose (which induces ex-
pression). We used a diploid strain to reduce the recovery of
extraneous mutations that simply perturb galactose metab-
olism; most such mutations are recessive. Of 3100 trans-
formants screened, 35 had strong growth-inhibition pheno-
types on galactose. Each was put through several secondary
screens to eliminate false positives and to eliminate muta-
tions that had complex interactions with spontaneous
genomic mutations (see MATERIALS AND METHODS for
details). Of the 22 mutants passing these secondary screens,
five were inhibited for growth on galactose at either 25 or
37°C, whereas 17 were inhibited for growth at 37°C but not
at 25°C.
Positions of Mutations
Unexpectedly, although wild-type HSP104 plasmids are
readily recovered from E. coli (Schirmer et al., 1994), the
mutant plasmids were not. Further experiments indicated
that this was due to toxicity of the mutant proteins in E. coli.
The GAL1 promoter is generally silent in this organism, but
we found that sequences in the leader region of HSP104
promoted transcription and, hence, protein expression
(Schirmer and Lindquist, unpublished data). This was in-
nocuous with the wild-type protein, but lethal with the
mutants. To circumvent this problem, the mutant genes
were recovered directly from yeast (where tight regulation
of the galactose promoter kept them silent) by PCR (see
MATERIALS AND METHODS). We focused on analysis of
six mutants, representing the two growth phenotypes (five
that inhibited growth at 25 or 37°C and one that inhibited
growth at 37°C but not 25°C). These six mutants contained a
total of 30 nucleotide changes, 22 of which created amino
acid substitutions (Figure 1). Among them, substitutions at
three residues in the 908-amino acid protein were recovered
more than once, suggesting that they are particularly impor-
tant in Hsp104p function. Notably, despite the low rate of
mutagenesis observed within the marker gene in the same
plasmid, every sequenced Hsp104p mutant contained mul-
tiple substitutions. This suggested that more than one mu-
tation might generally be required to produce a dominant
growth-inhibition phenotype for Hsp104p, a suggestion con-
firmed by further analysis (see below).
Ten of the 22 amino acid altering mutations occurred in
the first nucleotide-binding domain (NBD1); four of these
were in or very near the Walker A and B consensus se-
quences of the highly conserved phosphate-binding loop
(P-loop; Walker et al., 1982; Saraste et al., 1990; Leipe et al.,
2002). Two occurred in the putative sensor 2 consensus of
NBD1, which is thought to be located after the MR (Neu-
wald et al., 1999). Unexpectedly, seven of the remaining 12
substitutions clustered in the highly variable MR. In fact,
every mutant recovered in the screen for disruption of
Hsp104p regulation had at least one MR mutation.
Although the amino acid sequence of the MR is highly
variable, one small segment of 11 residues (Figure 2) exhibits
moderate conservation among those members of the
HSP100 family that function in thermotolerance (including
plant, bacterial, and fungal members; Gottesman et al., 1990;
Schirmer et al., 1996). Five of the seven MR mutations recov-
ered in our screen were located in this small conserved
segment (Figures 1, open box under MR; and 2).
All mutant proteins that affected growth at both temper-
atures carried at least one NBD mutation in addition to the
MR mutation. The mutant that affected growth only at 37°C
did not contain an NBD substitution. We chose one mutant
from each of the two growth-inhibition categories for further
detailed analysis. G217S/T499I was selected because it was
independently recovered twice in the screen (the second
time with an additional mutation; Figure 1) and had a rela-
tively small number of substitutions. A503V/A509D was
selected because its ability to block growth was temperature
dependent.
General Characterization of Mutants
We first confirmed that the Hsp104p mutations were solely
responsible for the selected phenotypes by recreating the
mutant alleles through directed mutagenesis in fresh plas-
mids and fresh strains (our unpublished data). Next, we
asked whether the growth-inhibition phenotype was depen-
dent on either the high levels of expression characteristic of
the GAL1 promoter or some feature of galactose metabolism
or galactose-regulated gene expression. The mutants were
transferred to galactose expression vectors with different
selectable markers (plasmids pGALSc104, 104b-U1, and
HSP104-b/Leu; Table 2). A hormone-responsive promoter
(Louvion et al., 1993) and a methionine-regulated promoter
(Korch et al., 1991) were tested as alternative induction sys-
tems (see MATERIALS AND METHODS). The phenotypes
of the two mutants were reproduced with all induction
E.C. Schirmer et al.
Molecular Biology of the Cell2064
systems, which varied 20-fold in the levels of protein they
produced (our unpublished data), and with different select-
able markers. Thus, the mutant phenotypes do not require
high levels of protein expression and are not specific to any
particular nutritional state.
Third, we addressed the possibility that the phenotypes
were not due to the activities of the mutant proteins
themselves, but rather to their ability to form mixed com-
plexes with wild-type Hsp104p and perturb its function.
Because Hsp104p functions in a hexameric complex, and
the strain used in the screen expressed wild-type
Hsp104p, mixed hexamers were probably formed. We
compared plasmid-dependent phenotypes in isogenic
wild-type and hsp104 deletion strains (Figure 3A). Each of
the phenotypes was recapitulated in both genetic back-
grounds: Hsp104pG217S/T499I inhibited growth at 25 or
37°C, and Hsp104pA503V/A509D inhibited growth only at
37°C. However, both growth defects were more severe in
the hsp104 background (Figure 3A, 37°C; our unpub-
lished data). We conclude that the loss-of-growth pheno-
types were not dependent upon interaction with wild-
type Hsp104p, and, indeed, were partially attenuated by
its presence.
Because the mutant proteins produce dominant gain-of-
function phenotypes, we asked whether their effects were
due to an alteration in their interaction with Sup35p, the
only known essential substrate of Hsp104p. Sup35p, a trans-
lation-termination factor, is the protein determinant of the
yeast prion [PSI] (reviewed in Serio and Lindquist, 2000).
The C-terminal region of Sup35p contains the essential
translation activity (Ter-Avanesyan et al., 1993), and the
N-terminal region confers upon Sup35p the capacity to as-
sume distinct prion and nonprion conformations. The
change between these states is regulated by interactions
between the N-terminal domain and Hsp104p (Patino et al.,
1996; Schirmer and Lindquist, 1997; Cashikar et al., 2002).
When Sup35p prion conversion is too efficient it can be toxic
(Ter-Avanesyan et al., 1993; Derkatch et al., 1996; Li and
Lindquist, 2000), because the essential translation-termina-
tion activity of the C-terminal domain is inhibited when the
protein is in the [PSI] state. Thus, it is possible that the
gain-of-function mutant HSP104 phenotypes were due to
excess conversion of Sup35p to the prion state. To examine
this possibility, we introduced a high-copy plasmid express-
ing the Sup35p C-terminal domain (Table 2), which does not
enter the prion state, into the mutant cells. Expression of the
C terminus alone did not mitigate the phenotype of either
Hsp104p mutant (our unpublished data). Therefore, the
growth inhibition caused by the Hsp104p mutants is not due
to an enhancement of Sup35p prion conversion.
Finally, we explored the basis of the temperature sensitiv-
ity of the A503V/A509D allele. When hsp104 cells carrying
the A503V/A509D mutant plasmid were grown at 37°C on
medium containing 0.5 M sorbitol, growth was restored
Figure 2. Mutations in the conserved sequence element within the
MR. The core of this element, KAAXLR, occurs in both the B and C
subfamilies of HSP100/Clp proteins; however, each has its own
variation. h, a hydrophobic residue.
Figure 3. Dominant lethal phenotypes of mutants. (A) HSP104
mutants inhibited growth. Wild-type (W303a) and hsp104 mutant
cells (SL304A) carrying pGALSc104, its mutant variants, or the
pLA1 vector control plasmid were first grown in noninducing liquid
medium. Equal numbers of cells were then spotted onto galactose
plates in fivefold serial dilutions (shown) to induce expression of the
mutant proteins, or onto glucose plates to repress synthesis
of the mutant proteins. No inhibition of growth was seen on
the glucose plates (not shown). (B) Sorbitol suppressed the
Hsp104pA503V/A509D mutant but not the Hsp104pG217S/T499I
mutant. SL304A (hsp104) cells carrying the same plasmids and
grown as in A were plated on galactose medium with or without
sorbitol.
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(Figure 3B). Because sorbitol stabilizes protein structure
(Gekko and Ito, 1990), this suggested that the mutant phe-
notype was caused by an effect of temperature on the struc-
tural state of the protein. Sorbitol can also stabilize cells
against cell lysis defects, but mutant cells had no such de-
fects. Further suggesting that the temperature sensitivity of
the Hsp104pA503V/A509D phenotype involves a protein-fold-
ing problem, it was partially suppressed by overexpression
of the chaperones Hsp90p and Sis1p (an HSP40 member; our
unpublished data). In contrast, neither sorbitol nor the chap-
erone proteins alleviated the non-temperature-sensitive phe-
notype of Hsp104pG217S/T499I.
Effects of Individual Substitutions on Growth
The fact that the mutants recovered in our original screen
contained more substitutions than expected (see MATERI-
ALS AND METHODS) suggested that more than one mu-
tation may generally be required to produce a dominant
growth-inhibiting form of Hsp104p. To investigate this, we
recreated the individual amino acid substitutions in two
plasmids, pGALSc104 and 104b-U1 and compared the phe-
notypes they produced with those of the original double
mutants in both wild-type (our unpublished data) and
hsp104 (Figure 4) strain backgrounds.
Neither G217S nor T499I alone produced a growth inhi-
bition at either 25°C (Figure 4, top left) or at 37°C (our
unpublished data). The single mutation A503V was suffi-
cient to recapitulate the growth-inhibition phenotype at
37°C. A509D alone produced no significant growth defect
(Figure 4, bottom left). In some experiments, with longer
incubations or higher cell densities, the A509D mutation
enhanced the severe growth defect caused by A503V (our
unpublished data).
We also tested individual substitutions from other mu-
tants recovered in the screen (A392T, A551T, P679L, and
T726I). None produced a growth-inhibition phenotype on its
own at either 25 or 37°C (our unpublished data). This sug-
gests that with rare exceptions, such as the A503V mutation
at high temperatures, gain-of-function growth-inhibiting
phenotypes require more than one mutation in Hsp104p.
Effects of Mutations on Thermotolerance Function
Next, we asked what effects the mutations had on Hsp104p’s
ability to perform its normal functions. Preliminary results
indicated that the mutations affected propagation of the
prion [PSI] (Chernoff, Schirmer, and Lindquist, unpub-
lished data). However, defining the molecular nature of
these effects was complicated by the fact that prion mainte-
nance is disrupted by either too much or too little Hsp104p
function. The relationship between Hsp104p and thermotol-
erance is simpler: the higher the concentration of Hsp104p,
the greater the thermotolerance (Lindquist and Kim, 1996).
Thermotolerance assays for Hsp104 function were possi-
ble with the mutant proteins because such assays use short-
term inductions, whereas growth-inhibition phenotypes re-
quire many hours of induction. Accordingly, mutant
proteins were induced with galactose to a level comparable
with that obtained with wild-type Hsp104p after a strong
tolerance-inducing preheat treatment. Cells were then ex-
posed to a severe heat shock at 50°C and plated on glucose
medium at normal temperatures to repress further expres-
sion of the mutant proteins and to determine whether they
had been able to increase the number of cells surviving the
heat shock.
Figure 5. ATPase activities of proteins carrying single substitu-
tions. Wild-type Hsp104p, Hsp104pT499I, Hsp104pA503V, and
Hsp104pA509D proteins were purified from E. coli. (A) Basal ATP
hydrolysis rates of each protein were assayed in a physiological salt
buffer by release of Pi from ATP. (B) To establish that the similarity
in ATP hydrolysis rates between Hsp104pA509D and wild-type
Hsp104p is not restricted to early time points, they were compared
over a range of time.
Figure 4. Phenotypes of individual mutations. Left, lethal pheno-
types. pGALSc104 plasmids carrying the individual or double sub-
stitutions were tested in strain SL304A (hsp104) on inducing me-
dium. Cells were grown at 25°C (top) or 37°C (bottom). Right,
thermotolerance phenotypes. Using the same strain and plasmids as
for the growth assessments, mutant proteins were first induced for
4 h. Cells were then pretreated at 37°C for 30 min (to induce other
tolerance factors) before an extreme heat stress of 50°C for 30 min.
To determine survival rates, cells were plated at 25°C on glucose
medium (which repressed further synthesis of the mutant protein).
All were plated in fivefold serial dilutions.
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Neither mutant protein had any effect on the thermotol-
erance function of the endogenous Hsp104p (our unpub-
lished data). In a hsp104 background, neither
Hsp104pG217S/T499I nor Hsp104pA503V/A509D was capable of
providing thermotolerance (Figure 4, right). Surprisingly,
the individual constituent mutations had very different ef-
fects (Figure 4, right). Protein containing only the T499I
mutation had thermotolerance function, but protein contain-
ing only the G217S mutation did not. Protein containing
only the A503V substitution, which severely inhibits growth
when continuously expressed at 37°C (Figure 4, left), con-
ferred wild-type levels, or greater, of thermotolerance (Fig-
ure 4, right). In contrast, protein containing only the A509D
substitution, which did not inhibit growth, had a greater
than 50-fold reduction in thermotolerance function relative
to wild-type Hsp104p. Similar results were obtained with
(Figure 4, right) and without (our unpublished data) a pre-
conditioning treatment at 37°C, that is, with or without other
heat-inducible factors.
MR Mutations Alter ATP Hydrolysis
Because Hsp104p function requires ATP hydrolysis (Parsell
et al., 1991; Schirmer et al., 1998), we examined the effects of
the mutations on ATPase activity. Due to difficulties in re-
covering the G217S/T499I double-mutant protein from bac-
teria and yeast cells, we confined the analysis to the indi-
vidual mutations.
The G217S substitution drastically lowered activity (our
unpublished data); this was not unexpected because a
G217V substitution (produced by site-directed mutagenesis,
Schirmer et al., 1998) lowers the ATPase activity of Hsp104p
to undetectable levels. Hsp104pT499I exhibited reduced ATP
hydrolysis (less than one-half that of wild-type; Figure 5A),
whereas Hsp104pA503V exhibited significantly elevated basal
ATPase activity at 37°C (Figure 5A; Cashikar et al., 2002).
Hsp104pA509D hydrolysis rates were indistinguishable from
those of wild-type protein (Figure 5, A and B). Thus, the
distinct phenotypes of the MR substitutions are associated
with distinct biochemical characteristics.
Aberrant Morphology Produced by Hsp104pG217S/T499I but
Not by Hsp104pA503V/A509D
Hsp104pG217S/T499I produced a striking morphological ab-
normality: cells arrested with elongated, often grossly dis-
tended buds in both wild-type and hsp104 backgrounds
(Figure 6A; our unpublished data). Electron microscopy re-
vealed abundant, abnormally placed cell wall material (Fig-
ure 6B) similar to that observed in cdc3 mutants (Slater et al.,
1985). In contrast, Hsp104pA503V/A509D produced no mor-
phological changes that were obvious, by either light or
electron microscopy (our unpublished data).
The similarity of the Hsp104pG217S/T499I phenotype to that
produced by mutant septin proteins (Hartwell, 1971; Slater
et al., 1985; Longtine et al., 1996; Gladfelter et al., 2001) led us
to investigate the effect of the mutant Hsp104p on septin
localization. To do so, we used antibodies specific to two
primary structural components of the septin ring, Cdc11p
(Figure 7) and Cdc3p (our unpublished data) (Ford and
Pringle, 1991; Kim et al., 1991). In cells arrested by
Hsp104pG217S/T499I, the septins often failed to localize to the
bud neck and sometimes formed linear strands or rings in
aberrant locations rather than normal rings at the neck (Fig-
ure 7, A and B).
To determine whether Hsp104pG217S/T499I colocalizes
with the misplaced septins, cells were stained with antibod-
ies specific to either the C terminus or the middle region of
Hsp104p (Cashikar et al., 2002). Both antibodies gave the
same pattern: cells expressing Hsp104pG217S/T499I often had
strong staining of aberrant ring structures superimposed on
diffuse general staining (Figure 7, A and B). These rings resem-
bled (Figure 7A) and seemed to colocalize with (Figure 7B) the
aberrant septin rings found in the same cells. In contrast, cells
expressing either Hsp104p or Hsp104pA503V/A509D exhibited
only diffuse Hsp104p staining (Figure 7; our unpublished
data). The diffuse staining of wild-type Hsp104p was absent at
the septin rings (Figure 7B, arrowheads). However, overex-
pression of wild-type Hsp104p did cause septin mislocalization
in some (5%) cells (Figure 7B, insets), suggesting that
Hsp104p does have a very weak intrinsic potential to interact
with the septin ring.
Mutations in CDC12 Partially Suppress the
G217S/T499I Phenotype
To investigate the nature of the interactions of
Hsp104pG217S/T499I with the septins, we conducted two
types of screens for suppressors of the Hsp104pG217S/T499I-
induced growth inhibition. First, we screened for proteins
that would suppress the mutant phenotype when overex-
Figure 6. Cells that express proteins carrying
the T499I substitution in combination with
NBD substitutions exhibit elongated buds with
misplaced cell-wall deposition. (A) Differential
interference contrast micrographs of hsp104
cells (strain SL304A) carrying the parent vector
or expressing Hsp104p, Hsp104pG217S/T499I, or
Hsp104pA392T/T499I/P679L. Elongated buds be-
gan to occur after 5–6 h of mutant protein ex-
pression. Cells were fixed at10 h. Bars, 10m.
(B) Electron microscopy of the hsp104G217S/T499I
mutant cells, grown as described in A. Material
resembling cell wall was deposited in strands or
sheets within the cell and between the mother
and daughter cells. Bars, 2 m.
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pressed. In a screen of approximately 1 million transfor-
mants from a galactose-inducible genomic expression li-
brary, no suppressors were isolated (see MATERIALS AND
METHODS). Second, using a mini-transposon insertion li-
brary, we searched for proteins whose deletion or truncation
would suppress the mutant phenotype. Screening of 105
transformants yielded two strains in which growth was
restored (see MATERIALS AND METHODS).
In both cases, suppression of the Hsp104pG217S/T499I-in-
duced growth defect was dominant when the haploid sup-
pressor strain was mated to a wild-type strain, and each
diploid yielded 2:2 segregation of the suppressor in all six
tetrads dissected. Surprisingly, suppression was unlinked to
the transposon insertion. Thus, the suppression must have
been due to spontaneous genomic mutations that were un-
related to the insertional mutagenesis. When the two sup-
pressor strains were mated and sporulated, all progeny ex-
hibited the suppressor phenotype, suggesting that the two
independently isolated suppressors mapped to the same
locus.
To identify this locus, we constructed a genomic library
from one of the suppressor strains and transformed it into
cells expressing Hsp104pG217S/T499I (see MATERIALS AND
METHODS). Transformants were screened for suppression
of the Hsp104pG217S/T499I loss-of-growth phenotype on ga-
lactose medium. Three plasmids that conferred suppression
were sequenced. All carried a mutant allele of the septin
gene CDC12 (K351N) in which the lysine was changed to
asparagine at residue 351, adjacent to the predicted coiled-
coil domain of Cdc12p (amino acids 356–407 as defined by
BioKnowledge Library [Incyte Palo Alto, CA]; amino acids
370–407, as defined using the algorithm of Wolf et al., 1997).
Sequencing the CDC12 locus of the second independently
obtained suppressor strain revealed a mutation in the same
region, E368Q, that changed glutamate to glutamine at po-
sition 368. Notably, Cdc12p is a component of the septin ring
at the mother-bud neck (Haarer and Pringle, 1987).
The suppressor strains expressing Cdc12pK351N or
Cdc12pE368Q grew well in the presence of Hsp104pG217S/T499I
(Figure 8A). Although some cells still exhibited the elon-
gated bud morphology, this was much less frequent and less
severe than in strains expressing Hsp104pG217S/T499I with-
out the mutant Cdc12p (Figures 6A and 8B). The ability of
each CDC12 mutant to suppress the Hsp104pG217S/T499I phe-
notype was confirmed by subcloning the mutant CDC12
open reading frames into plasmids and retesting them for
suppression. Each mutant allele, but not the wild-type
CDC12 allele, suppressed the growth defect of
Hsp104pG217S/T499I when expressed using either a galactose-
inducible promoter or the upstream region of CDC12 itself
(our unpublished data).
To determine whether the suppressors restored normal
septin localization in cells expressing Hsp104pG217S/T499I,
we used GFP fused at or near the N terminus of either
wild-type Cdc3p (Figure 8B) or wild-type Cdc12p (our un-
published data). Both proteins localized normally in wild-
type and CDC12 suppressor strain backgrounds in either the
presence or absence of wild-type Hsp104p (our unpublished
data). However, in cells expressing Hsp104pG217S/T499I, the
GFP-septins were mislocalized in virtually all cells express-
ing wild-type Cdc12p, but in only a fraction of those ex-
pressing the suppressor mutants Cdc12pK351N or
Cdc12pE368Q (Figure 8B).
The identification of mutant septin alleles as efficient sup-
pressors of Hsp104pG217S/T499I indicates that the toxic effect
of Hsp104pG217S/T499I is directly linked to the septin defects
observed after its induction. The lack of a visible septin
defect in strains expressing Hsp104pA503V/A509D suggested
that this mutant protein has a different mode of toxicity.
Indeed, the Cdc12p mutations (K351N and E368Q) did not
suppress the loss-of-growth phenotype of Hsp104pA503V/A509D
(our unpublished data).
Specificity of the Cell Morphology Phenotype
Neither of the CDC12 mutations produced a mutant pheno-
type on its own. Either in the presence of wild-type Hsp104p
or in its absence (a hsp104 strain), the cells grew at normal
Figure 7. Abnormal septin organization and colocalization of
Hsp104pG217S/T499I with the septins in cells expressing the mutant,
but not the wild-type, Hsp104p. SL304A (hsp104) cells expressing
wild-type Hsp104p (left) or Hsp104pG217S/T499I (right) were exam-
ined. (A) Cells were stained with polyclonal antibodies that recog-
nize either the C terminus of Hsp104p (top) or the Cdc11p septin
(bottom). Cells were fixed after 9 h of expression of wild-type or
mutant protein. No difference was observed between cells pro-
cessed with formaldehyde/Triton or with MeOH/acetone. Images
were obtained with an Olympus epifluorescence microscope. (B)
Cells were stained with an anti-Hsp104p monoclonal antibody
against the Hsp104p MR region and the anti-Cdc11p affinity-puri-
fied polyclonal antibody. Arrowheads, regions of septin rings,
showing little staining for Hsp104p. Inset, example of rare cells with
mislocalized septins in a cell overexpressing wild-type Hsp104p.
Cells were fixed after 12 h of expression. Photomicrographs are
confocal sections. Bars, 10 m.
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rates and seemed normal by light microscopy and septin
staining (our unpublished data). Thus, the Cdc12p mutations
did not perturb septin function. Rather, they specifically
and strongly suppressed the ability of Hsp104pG217S/T499I to
interact with the septin complex and perturb its function.
To determine whether the specificity of the bud morphol-
ogy defect observed with Hsp104pG217S/T499I was due to the
MR substitution (T499I) or to the NBD substitution (G217S),
we asked whether T499I produced a similar defect when
combined with other NBD mutations. The substitutions
A392T and P679L (originally isolated in combination with
other mutations; Figure 1) were chosen because they were
located in different structural elements than G217S (found in
the Walker A sequence of NBD1); A392 is located in box VII
of NBD1 (a highly conserved sequence motif; Neuwald et al.,
1999), whereas P679 occurs at the edge of the Walker B
sequence of NBD2. Neither A392T nor P679L produced a
thermotolerance defect on its own. In combination with each
other, they produced only a partial defect (our unpublished
data). More importantly, expression of these NBD mutants,
like that of the G217S mutant, produced no growth defects,
either alone or in combination (our unpublished data).
When the individual NBD mutations A392T or P679L were
combined with the T499I substitution (Hsp104pA392T/T499I or
Hsp104pT499I/P679L), no inhibition of growth was observed.
However, when both mutations were combined with T499I
(Hsp104pA392T/T499I/P679L), the triple mutant had the same
phenotype as Hsp104pG217S/T499I: growth inhibition was ob-
served that was not suppressed by sorbitol, elongated buds
were produced with misplaced septin rings, the mutant
Hsp104p colocalized with the septins, and the phenotype was
suppressed by both Cdc12pK351N and Cdc12pE368Q (Figure 6A,
right; our unpublished data). Thus, the specificity of this sep-
tin-assembly phenotype depended upon the MR substitution,
but its manifestation also required a perturbation of NBD func-
tion.
DISCUSSION
Critical Role of the Middle Region
Using random mutagenesis, we have conducted a screen for
mutations that disrupt the normally tight regulation of
Hsp104p activity. Specifically, we looked for mutations that
created a dominant gain-of-function effect that blocks cell
growth. To our knowledge, this is the first such screen
conducted with any member of the large superfamily of
AAA proteins. It has provided important and unexpected
insights, suggesting a promising strategy for study of other
members of this broad family. Every mutant we isolated
depended upon a substitution in the MR of Hsp104p to exert
its effect. This unequivocally demonstrates the importance of
the MR, a region little studied and, until recently, thought to
be of little significance.
Beyond establishing the MR as an important region, our
work pinpoints a small, moderately conserved sequence of
11 amino acids (residues 499–509) as being particularly crit-
ical for Hsp104p function. Remarkably, three single amino
acid substitutions found in this region caused extremely
diverse alterations of Hsp104p function. Hsp104pA503V
strongly inhibited growth at 37°C, yet it could promote
survival after extreme stress as effectively as wild-type
Hsp104p. Conversely, the MR mutant Hsp104pA509D had no
deleterious effect on growth but strongly impaired thermo-
tolerance function. (It is the first Hsp104p mutation to impair
thermotolerance without also reducing basal ATP hydroly-
sis.) The third MR mutant, Hsp104pT499I, had reduced ATP
Figure 8. Suppression of the G217S/T499I mutant by mutations in
CDC12. (A) hsp104 strains A3224 (CDC12), A3685 (CDC12K351N),
and A3686 (CDC12E368Q) carrying plasmid HSP104(G217S/T499I)-
b/Leu were grown to mid-log phase in SD and plated on SG
inducing medium at 30°C in fivefold serial dilutions. (B) Strains
used in A were transformed with the additional plasmid GFP-
CDC3, grown to late log phase in SD, washed, and induced in SG for
13 h. Cells were viewed live by confocal microscopy. Pictures are
merged differential interference contrast and GFP images. Bar, 10
m. Insets, cells at higher magnification with arrows denoting
Cdc3p septin fluorescence. Linear septin strands were only ob-
served in the presence of wild-type (WT) Cdc12p; mislocalized
septin rings were observed with WT and occasionally with the
mutant forms of Cdc12p.
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hydrolysis but was able to confer thermotolerance and did
not affect growth. Strikingly, the combination of T499I with
very different mutations in the NBDs of Hsp104p (G217S or
A392T plus P679L) caused mislocalization of septins and
associated defects in bud morphogenesis and cell wall dep-
osition.
The importance of the MR in Hsp104p function was un-
expected due to its extreme variability: it is the most diverse
region among class 1 HSP100/Clp proteins, in both length
and sequence (Gottesman et al., 1990; Schirmer et al., 1996).
In fact, it has previously been termed, very naturally, the
“spacer” region (Gottesman et al., 1990). It is also highly
variable even among members of the B-type HSP100 pro-
teins from plants, bacteria, and fungi (Schirmer et al., 1996),
all of which function in stress tolerance (Figure 2). While this
manuscript was in preparation, a complete deletion of the
MR in the E. coli HSP100 protein ClpB was found to block
the protein’s chaperone activity without affecting its stability
or expression levels (Mogk et al., 2003). This strongly sug-
gests that despite variation in its sequence, the MR will
prove to have important functions in all members of this
large family of protein-remodeling factors.
Further biochemical analysis of the A503V substitution in
our laboratory (Cashikar et al., 2002) has suggested that it
disrupts the mechanism of communication between
Hsp104p’s two NBDs. When poly-lysine binds the C-termi-
nal region of wild-type Hsp104p, it triggers nucleotide hy-
drolysis in NBD2, which in turn causes a conformational
change in the MR and stimulates hydrolysis at NBD1. Pro-
tein carrying the A503V substitution binds poly-lysine but
does not respond with elevated hydrolysis. The unpublished
crystal structure of the Thermus thermophilus ClpB protein
indicates that the MR forms a large coiled-coil domain in a
position where it might influence communication between
the two NBDs (Lee and Tsai, personal communication). The
11-amino acid sequence that we have identified by genetic
analysis as critical for Hsp104p function lies at one apex of
the coiled-coil domain. Together, genetic, structural, and
biochemical data from several laboratories are beginning to
produce a picture of how interdomain communication
might be involved in driving the complex conformational
changes that are the heart of Hsp104p function.
Molecular Explanation for a Gain-of-Function Phenotype
In addition to establishing that changes in the MR can pro-
duce dominant gain-of-function mutations in Hsp104p, we
have used cell biological and genetic methods to provide a
specific molecular explanation for one of the phenotypes.
Hsp104pG217S/T499I affects cell morphology by interacting
with the septins. This effect on morphology was unexpected
for several reasons: 1) no other Hsp104 mutant analyzed to
date (in this or several other studies) affects morphology; 2)
deletion of HSP104 has no effect on septin localization or cell
morphology, either at 25°C or at higher temperatures; and 3)
even very strong overexpression of wild-type Hsp104p
causes septin mislocalization in only a few cells. Either wild-
type Hsp104p does not interact with septins, or Hsp104p has
a weak ability to interact with septins, but this interaction is
transient and unimportant under laboratory conditions. It
might facilitate assembly or disassembly of the septin ring in
a manner that matters under some circumstances in the
wild. Regardless, the phenotype is a novel gain of function,
in which a potentially very weak intrinsic capacity to inter-
act with the septins is strongly enhanced by the T499I mu-
tation in the MR.
An extensive search for suppressors of the Hsp104pG217S/T499I
growth defect failed to uncover any high-copy suppressors
or deletion mutant suppressors. Instead, two spontaneous
genomic suppressor mutations were found, each residing in
CDC12, which encodes a component of the septin ring
(Haarer and Pringle, 1987; Longtine et al., 1996) and of the
septin complex that can assemble into filaments in vitro
(Frazier et al., 1998). Interestingly, Cdc12p resembles the best
characterized substrate of Hsp104p, the NM domain of the
Sup35p prion protein, which forms filaments and has a
domain enriched in lysines (Glover et al., 1997) that influ-
ences its interaction with Hsp104p (Liu et al., 2002). The two
independently isolated Cdc12p suppressor mutants,
Cdc12pK351N and Cdc12pE368Q, each contained a substitu-
tion in a lysine-rich region.
Although specificity of the Hsp104pG217S/T499I mutation
for interaction with the septins is dictated by the T499I
substitution, the associated phenotype requires an addi-
tional impairment of Hsp104p NBD function. The fact that
perturbation of septin structure by either Hsp104pG217S/T499I
or Hsp104pA392T/T499I/P679L is accompanied by colocaliza-
tion of the protein with the septins suggests that impairment
of ATPase activity inhibits the release of binding with
Cdc12p. Thus, the Hsp104pG217S/T499I:Cdc12p interaction
may represent a snapshot of the normally very transient
interaction between this AAA protein and its substrates,
which has been difficult to capture with wild-type protein.
In conjunction with the Cdc12p suppressors, the
Hsp104pG217S/T499I mutant could serve as a valuable tool for
further exploration of the determinants of Hsp104p sub-
strate recognition.
The Evolution of AAA Protein Functions
A common theme in molecular evolution is the radiation of
proteins with broad functions into a class of proteins that fill
specific niches through alterations in their regulation and
substrate selection. In some cases, such as the acquisition of
a new domain, the process leading to the acquisition of a
novel function is clearly defined (Patthy, 2003). It remains a
major puzzle, however, for the broad superfamily of AAA
proteins, which couple the function of their ATP-hydrolysis
domains to the remodeling of a bewildering variety of sub-
strates. Our gain-of-function mutants provide an enticing
picture of how such radiations might occur. Single amino
acid changes in one small region of the protein can create a
variety of functionally distinct mutants. Thus, it becomes
possible to imagine how subtle changes in Hsp104p MR
sequence and NBD function could serve to modulate sub-
strate recognition and the duration of substrate interactions,
as we have observed in our Hsp104pG217S/T499I mutant.
Hence, the apparent paradox we have uncovered, that the
most variable region in the broad family of proteins to which
Hsp104p belongs plays such a critical role in Hsp104p func-
tion, can be resolved. Some MR residues may vary due to
low sequence constraints, but others may vary precisely
because they are so important that they provide an oppor-
tunity to rapidly modulate the function and specificity of the
protein during evolution.
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